Cellectis
CLLS
#7754
Rank
A$0.51 B
Marketcap
A$5.08
Share price
0.28%
Change (1 day)
94.87%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: A$0.51 Billion

As of February 2026 Cellectis has a market cap of A$0.51 Billion. This makes Cellectis the world's 7754th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.51 B-27.05%
2025A$0.71 B207.65%
2024A$0.23 B-28.54%
2023A$0.32 B125.03%
2022A$0.14 B-72.78%
2021A$0.52 B-68.14%
2020A$1.65 B55.65%
2019A$1.06 B2.54%
2018A$1.03 B-19.53%
2017A$1.29 B53.7%
2016A$0.84 B-43.01%
2015A$1.47 B175.47%
2014A$0.53 B612.85%
2013A$75.06 M

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Cellectis was reported to be:

A$0.36 Billion
by Nasdaq info icon info icon
A$0.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
A$117.91 B 22,619.18%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
A$2.38 B 359.12%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
A$1.92 B 271.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
A$0.65 B 26.93%๐Ÿ‡บ๐Ÿ‡ธ USA